 | • レポートコード：MRC2102QY2417 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のがんヤヌスキナーゼ阻害剤市場について種類別（モメロチニブ、レスタウルチニブ、パクリチニブ）、用途別（肺がん、卵巣がん、乳がん、膵臓がん、肝細胞がん、結腸直腸がん、頭頸部扁平上皮がん、前立腺がん、膠芽腫）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・がんヤヌスキナーゼ阻害剤市場の概要 ・世界の主要地域別がんヤヌスキナーゼ阻害剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のがんヤヌスキナーゼ阻害剤市場規模2015-2026：種類別（モメロチニブ、レスタウルチニブ、パクリチニブ） ・世界のがんヤヌスキナーゼ阻害剤市場規模2015-2026：用途別（肺がん、卵巣がん、乳がん、膵臓がん、肝細胞がん、結腸直腸がん、頭頸部扁平上皮がん、前立腺がん、膠芽腫） ・がんヤヌスキナーゼ阻害剤の米国市場規模2015-2020 ・がんヤヌスキナーゼ阻害剤のヨーロッパ市場規模2015-2020 ・がんヤヌスキナーゼ阻害剤の中国市場規模2015-2020 ・がんヤヌスキナーゼ阻害剤の日本市場規模2015-2020 ・がんヤヌスキナーゼ阻害剤の東南アジア市場規模2015-2020 ・がんヤヌスキナーゼ阻害剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・がんヤヌスキナーゼ阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・がんヤヌスキナーゼ阻害剤の市場動向・機会・課題 ・調査の結論 |
The pan-JAK inhibitor tofacitinib improves the delivery of therapeutic antibodies in cancer. Monoclonal antibodies and antibody-drug conjugates (ADCs) directed against tumor antigens are increasingly used for therapy in a variety of cancers.
Market Analysis and Insights: Global Cancer Janus Kinase Inhibitor Market
The global Cancer Janus Kinase Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Cancer Janus Kinase Inhibitor Scope and Market Size
The global Cancer Janus Kinase Inhibitor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Janus Kinase Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Cancer Janus Kinase Inhibitor market is segmented into
Momelotinib
Lestaurtinib
Pacritinib
Segment by Application, the Cancer Janus Kinase Inhibitor market is segmented into
Lung Cancer
Ovarian Cancer
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal cancer
Head & Neck Squamous Cell Carcinoma
Prostate Cancer
Glioblastoma
The Cancer Janus Kinase Inhibitor market is analysed and market size information is provided by regions (countries). Segment by Application, the Cancer Janus Kinase Inhibitor market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Janus Kinase Inhibitor Market Share Analysis
Cancer Janus Kinase Inhibitor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Janus Kinase Inhibitor business, the date to enter into the Cancer Janus Kinase Inhibitor market, Cancer Janus Kinase Inhibitor product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Asana Biosciences
Astra Zeneca
Celon Pharmaceuticals
Dynamic Pharma
Eli Lilly
Gilead Sciences
Hanmi Pharmaceuticals
Incyte
Kyowa Hakko
Moleculin
Pfizer
1 Cancer Janus Kinase Inhibitor Market Overview
1.1 Cancer Janus Kinase Inhibitor Product Scope
1.2 Cancer Janus Kinase Inhibitor Segment by Type
1.2.1 Global Cancer Janus Kinase Inhibitor Sales by Type (2020-2026)
1.2.2 Momelotinib
1.2.3 Lestaurtinib
1.2.4 Pacritinib
1.3 Cancer Janus Kinase Inhibitor Segment by Application
1.3.1 Global Cancer Janus Kinase Inhibitor Sales Comparison by Application (2020-2026)
1.3.2 Lung Cancer
1.3.3 Ovarian Cancer
1.3.4 Breast Cancer
1.3.5 Pancreatic Cancer
1.3.6 Hepatocellular Carcinoma
1.3.7 Colorectal cancer
1.3.8 Head & Neck Squamous Cell Carcinoma
1.3.9 Prostate Cancer
1.3.10 Glioblastoma
1.4 Cancer Janus Kinase Inhibitor Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cancer Janus Kinase Inhibitor Sales Growth Rate (2015-2026)
1.4.2 Global Cancer Janus Kinase Inhibitor Revenue and Growth Rate (2015-2026)
1.4.3 Global Cancer Janus Kinase Inhibitor Price Trends (2015-2026)
2 Cancer Janus Kinase Inhibitor Estimate and Forecast by Region
2.1 Global Cancer Janus Kinase Inhibitor Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cancer Janus Kinase Inhibitor Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cancer Janus Kinase Inhibitor Sales Market Share by Region (2015-2020)
2.2.2 Global Cancer Janus Kinase Inhibitor Revenue Market Share by Region (2015-2020)
2.3 Global Cancer Janus Kinase Inhibitor Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cancer Janus Kinase Inhibitor Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cancer Janus Kinase Inhibitor Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cancer Janus Kinase Inhibitor Estimates and Projections (2015-2026)
2.4.2 Europe Cancer Janus Kinase Inhibitor Estimates and Projections (2015-2026)
2.4.3 China Cancer Janus Kinase Inhibitor Estimates and Projections (2015-2026)
2.4.4 Japan Cancer Janus Kinase Inhibitor Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cancer Janus Kinase Inhibitor Estimates and Projections (2015-2026)
2.4.6 India Cancer Janus Kinase Inhibitor Estimates and Projections (2015-2026)
3 Global Cancer Janus Kinase Inhibitor Competition Landscape by Players
3.1 Global Top Cancer Janus Kinase Inhibitor Players by Sales (2015-2020)
3.2 Global Top Cancer Janus Kinase Inhibitor Players by Revenue (2015-2020)
3.3 Global Cancer Janus Kinase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Janus Kinase Inhibitor as of 2019)
3.4 Global Cancer Janus Kinase Inhibitor Average Price by Company (2015-2020)
3.5 Manufacturers Cancer Janus Kinase Inhibitor Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cancer Janus Kinase Inhibitor Players (Opinion Leaders)
4 Global Cancer Janus Kinase Inhibitor Market Size by Type
4.1 Global Cancer Janus Kinase Inhibitor Historic Market Review by Type (2015-2020)
4.1.1 Global Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
4.1.2 Global Cancer Janus Kinase Inhibitor Revenue Market Share by Type (2015-2020)
4.1.3 Global Cancer Janus Kinase Inhibitor Price by Type (2015-2020)
4.2 Global Cancer Janus Kinase Inhibitor Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cancer Janus Kinase Inhibitor Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Janus Kinase Inhibitor Revenue Forecast by Type (2021-2026)
4.2.3 Global Cancer Janus Kinase Inhibitor Price Forecast by Type (2021-2026)
5 Global Cancer Janus Kinase Inhibitor Market Size by Application
5.1 Global Cancer Janus Kinase Inhibitor Historic Market Review by Application (2015-2020)
5.1.1 Global Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
5.1.2 Global Cancer Janus Kinase Inhibitor Revenue Market Share by Application (2015-2020)
5.1.3 Global Cancer Janus Kinase Inhibitor Price by Application (2015-2020)
5.2 Global Cancer Janus Kinase Inhibitor Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cancer Janus Kinase Inhibitor Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Janus Kinase Inhibitor Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Janus Kinase Inhibitor Price Forecast by Application (2021-2026)
6 United States Cancer Janus Kinase Inhibitor Market Facts & Figures
6.1 United States Cancer Janus Kinase Inhibitor Sales Market Share by Company (2015-2020)
6.2 United States Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
6.3 United States Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
7 Europe Cancer Janus Kinase Inhibitor Market Facts & Figures
7.1 Europe Cancer Janus Kinase Inhibitor Sales Market Share by Company (2015-2020)
7.2 Europe Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
7.3 Europe Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
8 China Cancer Janus Kinase Inhibitor Market Facts & Figures
8.1 China Cancer Janus Kinase Inhibitor Sales Market Share by Company (2015-2020)
8.2 China Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
8.3 China Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
9 Japan Cancer Janus Kinase Inhibitor Market Facts & Figures
9.1 Japan Cancer Janus Kinase Inhibitor Sales Market Share by Company (3015-3030)
9.2 Japan Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
9.3 Japan Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
10 Southeast Asia Cancer Janus Kinase Inhibitor Market Facts & Figures
10.1 Southeast Asia Cancer Janus Kinase Inhibitor Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
11 India Cancer Janus Kinase Inhibitor Market Facts & Figures
11.1 India Cancer Janus Kinase Inhibitor Sales Market Share by Company (2015-2020)
11.2 India Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
11.3 India Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Cancer Janus Kinase Inhibitor Business
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Corporation Information
12.1.2 Abbott Laboratories Business Overview
12.1.3 Abbott Laboratories Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abbott Laboratories Cancer Janus Kinase Inhibitor Products Offered
12.1.5 Abbott Laboratories Recent Development
12.2 Asana Biosciences
12.2.1 Asana Biosciences Corporation Information
12.2.2 Asana Biosciences Business Overview
12.2.3 Asana Biosciences Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Asana Biosciences Cancer Janus Kinase Inhibitor Products Offered
12.2.5 Asana Biosciences Recent Development
12.3 Astra Zeneca
12.3.1 Astra Zeneca Corporation Information
12.3.2 Astra Zeneca Business Overview
12.3.3 Astra Zeneca Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Astra Zeneca Cancer Janus Kinase Inhibitor Products Offered
12.3.5 Astra Zeneca Recent Development
12.4 Celon Pharmaceuticals
12.4.1 Celon Pharmaceuticals Corporation Information
12.4.2 Celon Pharmaceuticals Business Overview
12.4.3 Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Products Offered
12.4.5 Celon Pharmaceuticals Recent Development
12.5 Dynamic Pharma
12.5.1 Dynamic Pharma Corporation Information
12.5.2 Dynamic Pharma Business Overview
12.5.3 Dynamic Pharma Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Dynamic Pharma Cancer Janus Kinase Inhibitor Products Offered
12.5.5 Dynamic Pharma Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Corporation Information
12.6.2 Eli Lilly Business Overview
12.6.3 Eli Lilly Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Eli Lilly Cancer Janus Kinase Inhibitor Products Offered
12.6.5 Eli Lilly Recent Development
12.7 Gilead Sciences
12.7.1 Gilead Sciences Corporation Information
12.7.2 Gilead Sciences Business Overview
12.7.3 Gilead Sciences Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Gilead Sciences Cancer Janus Kinase Inhibitor Products Offered
12.7.5 Gilead Sciences Recent Development
12.8 Hanmi Pharmaceuticals
12.8.1 Hanmi Pharmaceuticals Corporation Information
12.8.2 Hanmi Pharmaceuticals Business Overview
12.8.3 Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Products Offered
12.8.5 Hanmi Pharmaceuticals Recent Development
12.9 Incyte
12.9.1 Incyte Corporation Information
12.9.2 Incyte Business Overview
12.9.3 Incyte Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Incyte Cancer Janus Kinase Inhibitor Products Offered
12.9.5 Incyte Recent Development
12.10 Kyowa Hakko
12.10.1 Kyowa Hakko Corporation Information
12.10.2 Kyowa Hakko Business Overview
12.10.3 Kyowa Hakko Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Kyowa Hakko Cancer Janus Kinase Inhibitor Products Offered
12.10.5 Kyowa Hakko Recent Development
12.11 Moleculin
12.11.1 Moleculin Corporation Information
12.11.2 Moleculin Business Overview
12.11.3 Moleculin Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Moleculin Cancer Janus Kinase Inhibitor Products Offered
12.11.5 Moleculin Recent Development
12.12 Pfizer
12.12.1 Pfizer Corporation Information
12.12.2 Pfizer Business Overview
12.12.3 Pfizer Cancer Janus Kinase Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Pfizer Cancer Janus Kinase Inhibitor Products Offered
12.12.5 Pfizer Recent Development
13 Cancer Janus Kinase Inhibitor Manufacturing Cost Analysis
13.1 Cancer Janus Kinase Inhibitor Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cancer Janus Kinase Inhibitor
13.4 Cancer Janus Kinase Inhibitor Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cancer Janus Kinase Inhibitor Distributors List
14.3 Cancer Janus Kinase Inhibitor Customers
15 Market Dynamics
15.1 Cancer Janus Kinase Inhibitor Market Trends
15.2 Cancer Janus Kinase Inhibitor Opportunities and Drivers
15.3 Cancer Janus Kinase Inhibitor Market Challenges
15.4 Cancer Janus Kinase Inhibitor Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Cancer Janus Kinase Inhibitor Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Cancer Janus Kinase Inhibitor Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Cancer Janus Kinase Inhibitor Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Cancer Janus Kinase Inhibitor Sales (MT) by Region (2015-2020)
Table 5. Global Cancer Janus Kinase Inhibitor Sales Market Share by Region (2015-2020)
Table 6. Global Cancer Janus Kinase Inhibitor Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Cancer Janus Kinase Inhibitor Revenue Share by Region (2015-2020)
Table 8. Global Cancer Janus Kinase Inhibitor Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Cancer Janus Kinase Inhibitor Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Cancer Janus Kinase Inhibitor Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Cancer Janus Kinase Inhibitor Revenue Share Forecast by Region (2021-2026)
Table 12. Global Cancer Janus Kinase Inhibitor (MT) of Key Companies (2015-2020)
Table 13. Global Cancer Janus Kinase Inhibitor Sales Share by Company (2015-2020)
Table 14. Global Cancer Janus Kinase Inhibitor Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Cancer Janus Kinase Inhibitor Revenue Share by Company (2015-2020)
Table 16. Global Cancer Janus Kinase Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Janus Kinase Inhibitor as of 2019)
Table 17. Global Cancer Janus Kinase Inhibitor Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Cancer Janus Kinase Inhibitor Manufacturing Sites and Area Served
Table 19. Manufacturers Cancer Janus Kinase Inhibitor Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Cancer Janus Kinase Inhibitor Players
Table 22. Global Cancer Janus Kinase Inhibitor Sales (MT) by Type (2015-2020)
Table 23. Global Cancer Janus Kinase Inhibitor Sales Share by Type (2015-2020)
Table 24. Global Cancer Janus Kinase Inhibitor Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Cancer Janus Kinase Inhibitor Price (MT) by Type (2015-2020)
Table 26. Global Cancer Janus Kinase Inhibitor Sales Share by Type (2021-2026)
Table 27. Global Cancer Janus Kinase Inhibitor Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Cancer Janus Kinase Inhibitor Revenue Share by Type (2021-2026)
Table 29. Global Cancer Janus Kinase Inhibitor Price (MT) by Type (2021-2026)
Table 30. Global Cancer Janus Kinase Inhibitor Sales (MT) by Application (2015-2020)
Table 31. Global Cancer Janus Kinase Inhibitor Sales Share by Application (2015-2020)
Table 32. Global Cancer Janus Kinase Inhibitor Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Cancer Janus Kinase Inhibitor Price (MT) by Application (2015-2020)
Table 34. Global Cancer Janus Kinase Inhibitor Sales (MT) by Application (2021-2026)
Table 35. Global Cancer Janus Kinase Inhibitor Sales Share by Application (2021-2026)
Table 36. Global Cancer Janus Kinase Inhibitor Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Cancer Janus Kinase Inhibitor Revenue Share by Application (2021-2026)
Table 38. Global Cancer Janus Kinase Inhibitor Price (MT) by Application (2021-2026)
Table 39. United States Cancer Janus Kinase Inhibitor Sales (MT) by Company (2015-2020)
Table 40. United States Cancer Janus Kinase Inhibitor Sales Market Share by Company (2015-2020)
Table 41. United States Cancer Janus Kinase Inhibitor Sales (MT) by Type (2015-2020)
Table 42. United States Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
Table 43. United States Cancer Janus Kinase Inhibitor Sales (MT) by Application (2015-2020)
Table 44. United States Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
Table 45. Europe Cancer Janus Kinase Inhibitor Sales (MT) by Company (2015-2020)
Table 46. Europe Cancer Janus Kinase Inhibitor Sales Market Share by Company (2015-2020)
Table 47. Europe Cancer Janus Kinase Inhibitor Sales (MT) by Type (2015-2020)
Table 48. Europe Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
Table 49. Europe Cancer Janus Kinase Inhibitor Sales (MT) by Application (2015-2020)
Table 50. Europe Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
Table 51. China Cancer Janus Kinase Inhibitor Sales (MT) by Company (2015-2020)
Table 52. China Cancer Janus Kinase Inhibitor Sales Market Share by Company (2015-2020)
Table 53. China Cancer Janus Kinase Inhibitor Sales (MT) by Type (2015-2020)
Table 54. China Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
Table 55. China Cancer Janus Kinase Inhibitor Sales (MT) by Application (2015-2020)
Table 56. China Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
Table 57. Japan Cancer Janus Kinase Inhibitor Sales (MT) by Company (2015-2020)
Table 58. Japan Cancer Janus Kinase Inhibitor Sales Market Share by Company (2015-2020)
Table 59. Japan Cancer Janus Kinase Inhibitor Sales (MT) by Type (2015-2020)
Table 60. Japan Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
Table 61. Japan Cancer Janus Kinase Inhibitor Sales (MT) by Application (2015-2020)
Table 62. Japan Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Cancer Janus Kinase Inhibitor Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Cancer Janus Kinase Inhibitor Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Cancer Janus Kinase Inhibitor Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Cancer Janus Kinase Inhibitor Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
Table 69. India Cancer Janus Kinase Inhibitor Sales (MT) by Company (2015-2020)
Table 70. India Cancer Janus Kinase Inhibitor Sales Market Share by Company (2015-2020)
Table 71. India Cancer Janus Kinase Inhibitor Sales (MT) by Type (2015-2020)
Table 72. India Cancer Janus Kinase Inhibitor Sales Market Share by Type (2015-2020)
Table 73. India Cancer Janus Kinase Inhibitor Sales (MT) by Application (2015-2020)
Table 74. India Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
Table 75. Abbott Laboratories Corporation Information
Table 76. Abbott Laboratories Description and Business Overview
Table 77. Abbott Laboratories Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Abbott Laboratories Cancer Janus Kinase Inhibitor Product
Table 79. Abbott Laboratories Recent Development
Table 80. Asana Biosciences Corporation Information
Table 81. Asana Biosciences Description and Business Overview
Table 82. Asana Biosciences Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Asana Biosciences Cancer Janus Kinase Inhibitor Product
Table 84. Asana Biosciences Recent Development
Table 85. Astra Zeneca Corporation Information
Table 86. Astra Zeneca Description and Business Overview
Table 87. Astra Zeneca Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Astra Zeneca Cancer Janus Kinase Inhibitor Product
Table 89. Astra Zeneca Recent Development
Table 90. Celon Pharmaceuticals Corporation Information
Table 91. Celon Pharmaceuticals Description and Business Overview
Table 92. Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Product
Table 94. Celon Pharmaceuticals Recent Development
Table 95. Dynamic Pharma Corporation Information
Table 96. Dynamic Pharma Description and Business Overview
Table 97. Dynamic Pharma Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Dynamic Pharma Cancer Janus Kinase Inhibitor Product
Table 99. Dynamic Pharma Recent Development
Table 100. Eli Lilly Corporation Information
Table 101. Eli Lilly Description and Business Overview
Table 102. Eli Lilly Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Eli Lilly Cancer Janus Kinase Inhibitor Product
Table 104. Eli Lilly Recent Development
Table 105. Gilead Sciences Corporation Information
Table 106. Gilead Sciences Description and Business Overview
Table 107. Gilead Sciences Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Gilead Sciences Cancer Janus Kinase Inhibitor Product
Table 109. Gilead Sciences Recent Development
Table 110. Hanmi Pharmaceuticals Corporation Information
Table 111. Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Hanmi Pharmaceuticals Description and Business Overview
Table 113. Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Product
Table 114. Hanmi Pharmaceuticals Recent Development
Table 115. Incyte Corporation Information
Table 116. Incyte Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Incyte Description and Business Overview
Table 118. Incyte Cancer Janus Kinase Inhibitor Product
Table 119. Incyte Recent Development
Table 120. Kyowa Hakko Corporation Information
Table 121. Kyowa Hakko Description and Business Overview
Table 122. Kyowa Hakko Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Kyowa Hakko Cancer Janus Kinase Inhibitor Product
Table 124. Kyowa Hakko Recent Development
Table 125. Moleculin Corporation Information
Table 126. Moleculin Description and Business Overview
Table 127. Moleculin Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Moleculin Cancer Janus Kinase Inhibitor Product
Table 129. Moleculin Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Cancer Janus Kinase Inhibitor Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Pfizer Cancer Janus Kinase Inhibitor Product
Table 134. Pfizer Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Cancer Janus Kinase Inhibitor Distributors List
Table 138. Cancer Janus Kinase Inhibitor Customers List
Table 139. Cancer Janus Kinase Inhibitor Market Key Trends
Table 140. Cancer Janus Kinase Inhibitor Key Opportunities and Drivers
Table 141. Cancer Janus Kinase Inhibitor Market Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Janus Kinase Inhibitor Product Picture
Figure 2. Global Cancer Janus Kinase Inhibitor Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cancer Janus Kinase Inhibitor Market Share by Application in 2020 & 2026
Figure 6. Lung Cancer Examples
Figure 7. Ovarian Cancer Examples
Figure 8. Breast Cancer Examples
Figure 9. Pancreatic Cancer Examples
Figure 10. Hepatocellular Carcinoma Examples
Figure 11. Colorectal cancer Examples
Figure 12. Head & Neck Squamous Cell Carcinoma Examples
Figure 13. Prostate Cancer Examples
Figure 14. Glioblastoma Examples
Figure 15. Global Cancer Janus Kinase Inhibitor Sales (MT) Growth Rate (2015-2026)
Figure 16. Global Cancer Janus Kinase Inhibitor Revenue (US$ Million) Growth Rate (2015-2026)
Figure 17. Global Cancer Janus Kinase Inhibitor Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 18. Global Cancer Janus Kinase Inhibitor Revenue Market Share by Region: 2015 VS 2020
Figure 19. Global Cancer Janus Kinase Inhibitor Revenue Market Share by Region: 2021 VS 2026
Figure 20. United States Cancer Janus Kinase Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. United States Cancer Janus Kinase Inhibitor Sales (MT) Growth Rate (2015-2026)
Figure 22. Europe Cancer Janus Kinase Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Europe Cancer Janus Kinase Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 24. China Cancer Janus Kinase Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. China Cancer Janus Kinase Inhibitor Sales (Million USD) and Growth Rate (2015-2026)
Figure 26. Japan Cancer Janus Kinase Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. Japan Cancer Janus Kinase Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Southeast Asia Cancer Janus Kinase Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 29. Southeast Asia Cancer Janus Kinase Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 30. India Cancer Janus Kinase Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 31. India Cancer Janus Kinase Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 32. Global 5 Largest Cancer Janus Kinase Inhibitor Players Market Share by Revenue in Cancer Janus Kinase Inhibitor 2015 & 2019
Figure 33. Cancer Janus Kinase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 34. Global Cancer Janus Kinase Inhibitor Revenue Share by Type (2015-2020)
Figure 35. Global Cancer Janus Kinase Inhibitor Revenue Growth Rate by Type in 2015 & 2019
Figure 36. Global Cancer Janus Kinase Inhibitor Revenue Share by Application (2015-2020)
Figure 37. Global Cancer Janus Kinase Inhibitor Revenue Growth Rate by Application in 2015 & 2019
Figure 38. United States Cancer Janus Kinase Inhibitor Sales Market Share by Type in 2019
Figure 39. United States Cancer Janus Kinase Inhibitor Sales Market Share by Type in 2019
Figure 40. Europe Cancer Janus Kinase Inhibitor Sales Market Share by Company in 2019
Figure 41. Europe Cancer Janus Kinase Inhibitor Sales Market Share by Type in 2019
Figure 42. Europe Cancer Janus Kinase Inhibitor Sales Market Share by Application in 2019
Figure 43. China Cancer Janus Kinase Inhibitor Sales Market Share by Company in 2019
Figure 44. China Cancer Janus Kinase Inhibitor Sales Market Share by Type in 2019
Figure 45. China Cancer Janus Kinase Inhibitor Sales Market Share by Application in 2019
Figure 46. Japan Cancer Janus Kinase Inhibitor Sales Market Share by Company in 2019
Figure 47. Japan Cancer Janus Kinase Inhibitor Sales Market Share by Type in 2019
Figure 48. Japan Cancer Janus Kinase Inhibitor Sales Market Share by Application in 2019
Figure 49. Southeast Asia Cancer Janus Kinase Inhibitor Sales Market Share by Company in 2019
Figure 50. Southeast Asia Cancer Janus Kinase Inhibitor Sales Market Share by Type in 2019
Figure 51. Southeast Asia Cancer Janus Kinase Inhibitor Sales Market Share by Application in 2019
Figure 52. India Cancer Janus Kinase Inhibitor Sales Market Share by Company in 2019
Figure 53. India Cancer Janus Kinase Inhibitor Sales Market Share by Type in 2019
Figure 54. India Cancer Janus Kinase Inhibitor Sales Market Share by Application in 2019
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Cancer Janus Kinase Inhibitor
Figure 57. Manufacturing Process Analysis of Cancer Janus Kinase Inhibitor
Figure 58. Cancer Janus Kinase Inhibitor Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
プロテインキナーゼ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Protein Kinase Inhibitor Market The global Protein Kinase Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Protein Kinase Inhibitor Scope and Market Size The global Protein …- がん診断装置の世界市場レポート2020 Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical compan…
- 非チロシンキナーゼ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Non-Tyrosine Kinase Inhibitors Market The global Non-Tyrosine Kinase Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Non-Tyrosine Kinase Inhibitors Scope and Market Size T…
- がん治療用放射性ステントの世界市場レポート2020 Radioactive stent, the self-expanding stent with radioactivity particles is regards as very useful in the treatment of medium and advanced esophageal cancer. Jiangsu Province is the largest suppling place as the top 3 manufacturers are located therem Micro-Tech, Changzhou Zhiye and Changzhou Garson.…
- がん画像システムの世界市場レポート2020 Market Analysis and Insights: Global Cancer Imaging System Market The global Cancer Imaging System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Cancer Imaging System Scope and Market Size The global Cancer Imaging Sy…